The implementation of the Plan Esperanza and response to the imPACT Review

Tatiana Vidaurre, Carlos Santos, Henry Gómez, Gustavo Sarria, Edgar Amorin, Marga López, Roxana Regalado, Javier Manrique, Duniska Tarco, Carlos Ayestas, Mónica Calderón, Luis Mas, Silvia Neciosup, Miriam Salazar, Juan Carlos Chávez, Milward Ubillus, Abel Limache, José Carlos Ubillus, Jeannie Navarro, Kavita SarwalSimon Sutcliffe, Alfonso Gutiérrez-Aguado, Marianela Silva, Amalia Mena, María Eugenia Guillén, Carlos Castañeda, Julio Abugattas

Research output: Contribution to journalReview articlepeer-review

28 Scopus citations


Following the implementation of the National Cancer Prevention and Control Results-based Budget Programme (PpR Cancer–024) in 2011, the Peruvian Government approved the Plan Esperanza—a population-based national cancer control plan—in 2012. Legislation that ensured full government-supported funding for people who were otherwise unable to access or afford care and treatment accompanied the Plan. In 2013, the Ministry of Health requested an integrated mission of the Programme of Action for Cancer Therapy (imPACT) report to strengthen cancer control in Peru. The imPACT Review, which was executed in 2014, assessed Peru's achievements in cancer control, and areas for improvement, including cancer control planning, further development of population-based cancer registration, increased prevention, early diagnosis, treatment and palliative care, and the engagement and participation of civil society in the health-care system. This Series paper gives a brief history of the development of the Plan Esperanza, describes the innovative funding model that supports it, and summarises how funds are disseminated on the basis of disease, geography, and demographics. An overview of the imPACT Review, and the government's response in the context of the Plan Esperanza, is provided. The development and execution of the Plan Esperanza and the execution of and response to the imPACT Review demonstrates the Peruvian Government's commitment to fighting cancer across the country, including in remote and urban areas.

Original languageEnglish
Pages (from-to)e595-e606
JournalThe Lancet Oncology
Issue number10
StatePublished - Oct 2017

Bibliographical note

Funding Information:
In 2011, the National Cancer Prevention and Control Results-based Budget Programme (PpR Cancer–024) was implemented in ten of the 25 regions of Peru. 3,6,13,15 The regions were chosen based on demographic, epidemiological, and readiness criteria, with an initial focus on the prevention of cervical, breast, lung, stomach, and prostate cancer. 3,6,13,15 Initially, screening and early diagnosis of the five most frequent types of cancer (cervical, breast, lung, gastric, and prostate) were covered. Mainly supported by the PpR Cancer–024, public financial protection for vulnerable populations, through SIS, was provided for all types of cancers. In 2012, specialised complementary financial support by the extensive coverage of SIS for high-cost diseases was made available to Peruvians through the Intangible Solidarity Health Fund (FISSAL). 5,15 Seven high-cost cancers were covered (breast, cervical, colon, stomach, prostate cancer, and leukaemia and lymphoma) through out-of-pocket financial protection coverage. 18 The implementation of the PpR Cancer–024, which was supported by INEN, and the creation of FISSAL by SIS, have been important milestones in the funding of Plan Esperanza. 14,19

Publisher Copyright:
© 2017 Elsevier Ltd


Dive into the research topics of 'The implementation of the Plan Esperanza and response to the imPACT Review'. Together they form a unique fingerprint.

Cite this